Ph2 Open-label Study of AOC 1044 in Duchenne Muscular Dystrophy Participants with Mutations Amenable to Exon44 Skipping

Recruiting

Phase 2

Ph2 Open-label Study of AOC 1044 in Duchenne Muscular Dystrophy Participants with Mutations Amenable to Exon44 Skipping

Sponsor:

Avidity Biosciences, Inc.

Code:

NCT06244082

Conditions

DMD

Duchenne Muscular Dystrophy

Duchenne

Exon 44

Eligibility Criteria

Sex: Male

Age: 7 - 27

Healthy Volunteers: Not accepted

Interventions

AOC 1044

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information